KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Chemed (CHE) EBIT (2016 - 2026)

Chemed filings provide 18 years of EBIT readings, the most recent being $84.6 million for Q1 2026.

  • For the quarter ending Q1 2026, EBIT fell 10.74% year-over-year to $84.6 million, compared with a TTM value of $328.1 million through Mar 2026, down 15.65%, and an annual FY2025 reading of $338.2 million, down 7.71% over the prior year.
  • EBIT hit $84.6 million in Q1 2026 for Chemed, down from $100.7 million in the prior quarter.
  • The five-year high for EBIT was $113.9 million in Q4 2024, with the low at -$192.9 million in Q4 2022.
  • Median EBIT over the past 5 years was $86.8 million (2023), compared with a mean of $70.5 million.
  • The largest YoY upside for EBIT was 157.74% in 2023 against a maximum downside of 24.4% in 2023.
  • Year by year, EBIT stood at -$192.9 million in 2022, then soared by 157.74% to $111.4 million in 2023, then rose by 2.23% to $113.9 million in 2024, then fell by 11.61% to $100.7 million in 2025, then decreased by 15.97% to $84.6 million in 2026.
  • According to Business Quant data, EBIT over the past three periods came in at $84.6 million, $100.7 million, and $74.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.